期刊文献+

盐酸多柔比星脂质体致急性喉头水肿1例的护理体会

Nursing Experience of One Case of Acute Laryngeal Edema Caused by Doxorubicin Hydrochloride Liposome
下载PDF
导出
摘要 1例老年男性患者因确诊外周T细胞淋巴瘤给予DA-EPOCH方案化疗,输注盐酸多柔比星脂质体后出现面部麻木、喉部发紧、颈部不适,伴有呼吸困难、舌部肿大、声音嘶哑、口齿不清等症状,查体见舌体肥大,颈部肿胀、增粗,遵医嘱予注射用甲泼尼龙琥珀酸钠、地塞米松静脉注射、10%葡萄糖酸钙静脉滴注,同时给予心电监护、氧气吸入,床边备中心负压吸引装置、气管插管导管、气管切开包,约2h后患者症状逐渐好转,生命体征平稳。疾病过程中护士及时发现患者并发症发生情况,配合医生给予对症治疗,密切观察患者病情变化,后患者安全化疗结束并出院。 An elderly male patient admitted to our hospital was diagnosed with peripheral T-cell lymphoma,and was treated with DA-EPOCH chemotherapy.During chemotherapy,facial numbness,gasping and neck discomfort,was accompanied by dyspnea,tongue swelling,hoarseness,and slurred speech when the patient was infused with doxorubicin hydrochloride liposome.Physical examination revealed hypertrophy of the tongue and swelling and thickening of the neck.The patient was given intravenous injection of methylprednisolone sodium succinate and dexamethasone,intravenous infusion of 10%calcium gluconate.At the same time,ECG monitoring,oxygen inhalation was given,and the central negative pressure suction device,endotracheal tube and tracheotomy packs were prepared at the bedside.About two hours later,the patient's symptoms gradually relieved and his vital signs were stable.In the course of this complication,the nurse observed the occurrence of complications in time,cooperated with the doctors to give emergency rescue,and further strengthened the inspection and monitoring of patients.The patient finally completed the chemotherapy uneventfully and was discharged after chemotherapy.
作者 钱玉霞 崔盈盈 QIAN Yu-xia;CUI Ying-ying(Taizhou People's Hospital,Taizhou Jiangsu 225300,China)
机构地区 泰州市人民医院
出处 《泰州职业技术学院学报》 2022年第2期80-82,86,共4页 Journal of Taizhou Polytechnic College
关键词 盐酸多柔比星 脂质体 过敏反应 喉头水肿 护理 doxorubicin hydrochloride liposome allergic reaction laryngeal edema nursing
  • 相关文献

参考文献5

二级参考文献38

  • 1吴海霞.盐酸多柔比星脂质体致过敏性休克1例的护理[J].上海护理,2007,7(1):71-72. 被引量:4
  • 2陈腾,茹小鹏,顾珊智,韩卫,贾晓俤,高雅,张秦初.药物不良事件及其法医学鉴定[J].法医学杂志,2007,23(1):26-29. 被引量:5
  • 3周孙昌.实用肿瘤内科学[M].2版.北京:人民卫生出版社,2002:501.
  • 4SLINGEKLAND M, GUCHELAAR HJ, GELDERBLOM H. Li-posomal drug formulations in cancer therapy : 15 years along theroad [ J ]. Drug Discov Today ,2012, 17(3-4): 160 -166.
  • 5ALLEN TM, HANSEN CB,DEMENEZES DEL. Pharmacokinet-ics of long cir-culating liposomes[ J]. Adv Drug Deliv Rev, 1995,16(2 - 3 ) : 267 -284.
  • 6NORTHFELT DW, MARTIN FJ,WORKING .,et al. Doxorubi-cin encapsu-lated in liposomes containing surface bound polyethy-lene glycol : plarmackinetics,tumor localization and safety in pa-tients with AIDS-related Kaposi, sarcoma [ J ]. J Clin Pharmacol,1996,36(1) ; 55 -63.
  • 7RIFKIN RM, GREGORY SA, MOHRBACHER AN,ef al. Pegy-lated liposomal doxorubicin, vincris-tine, and dexamethasoneprovide significant reductionin toxicity compared with doxorubi-cin ,vincristine, and dexamethasone in patients with newly diag-nosedmultiple myeloma[ J]. Cancer,2006 ,106(4) ;848 - 858.
  • 8KESTERSON JP,ODUNSI K, LELE S,et al. Highcumulativedoses of pegylated liposomal doxorubicin are notassociated withcardiac toxicity in patients with gynecologicmalignancies [ J ].Chemother, 2010, 56(2) : 108 -111.
  • 9O,BRIEN ME,WIGLER N,INBAR M, et al. Reducedcardio-toxicity and comparable efficacy in a phase III trial ofpegylated li-posomal doxorubicin HCl ( CAELYX/Doxil) versus conventionaldoxorubicin for first-line treatment ofmetastatic breast cancer[ J ].Ann Oncol, 2004,15(3) : 440 -449.
  • 10ANNE M , JEREMY W, MICHAEL L,et al. A phase II nonran-domized open-label study of liposomal daunorubicin ( DaunoX-ome) in advanced soft tissue sarcoma [ J ]. Sarcoma, 2006,1(1):1 -5.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部